Searchable abstracts of presentations at key conferences in endocrinology

ea0023oc2.2 | Oral Communications 2 | BSPED2009

Recombinant human GH improves linear growth in children with inflammatory bowel disease: results of a randomised controlled trial

Wong S C , Kumar P , Casson D H , Dalzell A M , Blair J C , Didi M , Hassan K , McGrogan P , Ahmed S F

Background: Despite optimal management, children with inflammatory bowel disease (IBD) may suffer from growth retardation. The role of rhGH in these children is unclear.Design: Randomised controlled trial of rhGH (0.067 mg/kg per day) for 6 months.Subjects: Twenty-two children with IBD and HtSDS<−2 or HtSDS<−1 and HVSDS<−1. Eleven were in the control group (C) and eleven in the treatment group (Rx).</p...